Publication:
Additive Value of EBUS-TBNA for Staging Non-Small Cell Lung Cancer in Patients Evaluated for Stereotactic Body Radiation Therapy

Métricas
Gestores bibliográficos

item.contributor.advisor

ORCID:

Journal Title

Journal ISSN

Volume Title

Publisher

item.page.isbn

item.page.issn

item.page.issne

item.page.extent

10 p.

item.page.accessRights

Acceso abierto

item.page.other

item.page.references

Abstract

Background/Objectives: Patients with non-small cell lung cancer (NSCLC) being evaluated for stereotactic body radiation therapy (SBRT) are frequently staged non-invasively with positron emission tomog...

Description

item.page.coverage.spatial

item.page.sponsorship

Citation

Boster, J. M., Goertzen, S. M., Sainz, P. V., Vial, M. R., Zaveri-Desai, J. K., Luna, L. D., Waqar, A., Grosu, H. B., Casal, R. F., Jimenez, C. A., Ost, D. E., Sabath, B. F., Lin, J., Hernandez, M., & Eapen, G. A. (2025). Additive Value of EBUS-TBNA for Staging Non-Small Cell Lung Cancer in Patients Evaluated for Stereotactic Body Radiation Therapy. Diagnostics, 15(17), 2136. https://doi.org/10.3390/diagnostics15172136

item.page.dc.rights

item.page.dc.rights.url

Estadísticas de uso
6 5 3 2 0
Febrero 2026Marzo 2026Abril 2026Mayo 2026Junio 2026Julio 2026Agosto 2026